Nektar Therapeutics To Present At Merrill Lynch Global Pharmaceutical, Biotechnology & Medtech Conference, Oppenheimer Diabetes Conference And UBS Investment Bank 2006 Global Life Sciences Conference

SAN CARLOS, Calif.--(BUSINESS WIRE)--Sept. 11, 2006--Nektar Therapeutics (Nasdaq:NKTR) will be presenting at the Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference in London, on Thursday, September 21 at 11:20am (UK Time). Chris Searcy, vice president of corporate development, will be presenting the corporate overview at Merrill Lynch. John Patton, co-founder and chief scientific officer, will be presenting at the Oppenheimer Diabetes Conference in New York, on Thursday, September 21 at 11:30am ET. Rob Chess, chairman and acting president and chief executive officer, will be presenting at the UBS Investment Bank 2006 Global Life Sciences Conference in New York, on Wednesday, September 27 at 8:00am (Eastern Time).